Jan 6, 2026 08:00AM
Dec 19, 2025 07:42AM
Oct 7, 2025 06:39AM
Aug 22, 2025 05:33AM
Apr 15, 2025 03:01PM
Apr 10, 2025 08:04AM
Apr 10, 2025 08:00AM Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema
Apr 1, 2025 04:00AM
Mar 13, 2025 06:41AM
Mar 12, 2025 09:18AM
Jan 7, 2025 06:52AM
Jan 6, 2025 02:12PM
Aug 28, 2024 06:43AM
Aug 27, 2024 04:00AM Oculis Reports Q2 2024 Financial Results and Provides Recent Company Update
Jun 11, 2024 06:42AM
Jun 11, 2024 05:24AM
Jun 10, 2024 05:00AM
Jun 10, 2024 04:30AM
Apr 10, 2024 06:30AM
Dec 20, 2023 06:30AM
Aug 8, 2023 06:30AM Oculis Holding (OCS) Reports OCS-01 Met Both Primary Endpoints in Phase 3 OPTIMIZE Trial
Aug 8, 2023 06:30AM
Apr 26, 2023 07:04AM
Apr 26, 2023 07:00AM
Apr 26, 2023 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All